190 related articles for article (PubMed ID: 32304645)
1. Boosting the arsenal against COVID-19 through computational drug repurposing.
Ciliberto G; Cardone L
Drug Discov Today; 2020 Jun; 25(6):946-948. PubMed ID: 32304645
[No Abstract] [Full Text] [Related]
2. Rapid repurposing of drugs for COVID-19.
Guy RK; DiPaola RS; Romanelli F; Dutch RE
Science; 2020 May; 368(6493):829-830. PubMed ID: 32385101
[No Abstract] [Full Text] [Related]
3. Fight against novel coronavirus: A perspective of medicinal chemists.
Amin SA; Jha T
Eur J Med Chem; 2020 Sep; 201():112559. PubMed ID: 32563814
[TBL] [Abstract][Full Text] [Related]
4.
Sachdeva C; Wadhwa A; Kumari A; Hussain F; Jha P; Kaushik NK
OMICS; 2020 Oct; 24(10):568-580. PubMed ID: 32757981
[TBL] [Abstract][Full Text] [Related]
5. Databases for the targeted COVID-19 therapeutics.
Wang Y; Li F; Zhang Y; Zhou Y; Tan Y; Chen Y; Zhu F
Br J Pharmacol; 2020 Nov; 177(21):4999-5001. PubMed ID: 32845521
[No Abstract] [Full Text] [Related]
6. Three Decades of Interferon-β in Multiple Sclerosis: Can We Repurpose This Information for the Management of SARS-CoV2 Infection?
Severa M; Farina C; Salvetti M; Coccia EM
Front Immunol; 2020; 11():1459. PubMed ID: 32655578
[No Abstract] [Full Text] [Related]
7. Drug repositioning is an alternative for the treatment of coronavirus COVID-19.
Serafin MB; Bottega A; Foletto VS; da Rosa TF; Hörner A; Hörner R
Int J Antimicrob Agents; 2020 Jun; 55(6):105969. PubMed ID: 32278811
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone nanomedicines for COVID-19.
Lammers T; Sofias AM; van der Meel R; Schiffelers R; Storm G; Tacke F; Koschmieder S; Brümmendorf TH; Kiessling F; Metselaar JM
Nat Nanotechnol; 2020 Aug; 15(8):622-624. PubMed ID: 32747742
[No Abstract] [Full Text] [Related]
9. Application of Artificial Intelligence in COVID-19 drug repurposing.
Mohanty S; Harun Ai Rashid M; Mridul M; Mohanty C; Swayamsiddha S
Diabetes Metab Syndr; 2020; 14(5):1027-1031. PubMed ID: 32634717
[TBL] [Abstract][Full Text] [Related]
10. Metabolomics to Predict Antiviral Drug Efficacy in COVID-19.
Migaud M; Gandotra S; Chand HS; Gillespie MN; Thannickal VJ; Langley RJ
Am J Respir Cell Mol Biol; 2020 Sep; 63(3):396-398. PubMed ID: 32574504
[No Abstract] [Full Text] [Related]
11. Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base.
Taccone FS; Gorham J; Vincent JL
Lancet Respir Med; 2020 Jun; 8(6):539-541. PubMed ID: 32304640
[No Abstract] [Full Text] [Related]
12. East meets West in COVID-19 therapeutics.
Wang S; Zeng X; Wang Y; Zhao Y; Chen W; Chen YZ
Pharmacol Res; 2020 Sep; 159():105008. PubMed ID: 32531323
[No Abstract] [Full Text] [Related]
13. Drug repurposing in the era of COVID-19: a call for leadership and government investment.
Martin JH; Bowden NA
Med J Aust; 2020 Jun; 212(10):450-452.e1. PubMed ID: 32372435
[No Abstract] [Full Text] [Related]
14. Drug researchers pursue new lines of attack against COVID-19.
Harrison C
Nat Biotechnol; 2020 Jun; 38(6):659-662. PubMed ID: 32417850
[No Abstract] [Full Text] [Related]
15. Potential Unconventional Medicines for the Treatment of SARS-CoV-2.
Coppola M; Mondola R
Drug Res (Stuttg); 2020 Jun; 70(6):286. PubMed ID: 32428941
[No Abstract] [Full Text] [Related]
16. Existing Drugs Might Treat COVID-19.
Abbasi J
JAMA; 2020 Jun; 323(22):2239. PubMed ID: 32515802
[No Abstract] [Full Text] [Related]
17. Mass Drug Administration and Worms Experience in Africa: Envisage Repurposing Ivermectin for SARS-COV-2.
Wamae CN
Am J Trop Med Hyg; 2020 Jul; 103(1):10-11. PubMed ID: 32458795
[No Abstract] [Full Text] [Related]
18. [Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease?].
Nisole S; Saulnier A; Gatignol A
Virologie (Montrouge); 2020 Jun; 24(3):135-141. PubMed ID: 32648548
[No Abstract] [Full Text] [Related]
19. Lung tissue distribution of drugs as a key factor for COVID-19 treatment.
Wang Y; Chen L
Br J Pharmacol; 2020 Nov; 177(21):4995-4996. PubMed ID: 32424836
[No Abstract] [Full Text] [Related]
20. [Not Available].
Nau JY
Rev Med Suisse; 2020 Mar; 16(687):606-607. PubMed ID: 32216186
[No Abstract] [Full Text] [Related]
[Next] [New Search]